Arrowpoint Partners: Funding, Team & Investors

Arrowpoint Investment Partners is an investment management firm operating a multi-strategy hedge fund platform focused on Asian markets. It employs top-down portfolio construction and robust infrastructure. The firm integrates diverse trading strategies:equities, quantitative, fixed income, and commodities:into a cohesive portfolio. This unified system leverages custom technology for efficient management across asset classes.

Jonathan Xiong launched Arrowpoint Investment Partners in July 2024. As former co-CEO of Millennium’s Asia operations, Xiong built the multi-strategy firm from inception. This integrated framework offers operational leverage, allowing managers to optimize market opportunities and mitigate risk effectively within a singular structure.

The firm targets institutional investors seeking strategic exposure to Asian financial markets. Arrowpoint’s vision prioritizes controlled growth, capping assets under management for optimal efficiency and service standards. The company aims to continually evolve its platform, delivering dynamic market access and adaptive investment solutions for its clientele.

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jun 1, 2016	Mersana Therapeutics	$33.0M Series C	Wellington Management	Avoro Ventures, OrbiMed, Versant Ventures, Elliott Sigal, Cormorant Asset Management, NEW Enterprise Associates, Rock Springs Capital, Takeda
May 20, 2016	Convene	$35.0M Debt / Series B Extension	Brookfield Property Partners	Boathouse Capital, Conversion Capital, Sunrise Capital Partners
Aug 1, 2015	Syndax Pharmaceuticals	$80.0M Series C	Delos, Fidelity Management & Research Company	Amoon Fund, Domain Associates, InterWest, Osage University Partners, T1D Fund, Vivo Capital, Biomed Ventures, Cormorant Asset Management, EcoR1 Capital, Forward Ventures, Greenwood Capital, Jennison Associates, MPM Capital, OrbiMed, Rusnanomedinvest, Tavistock Group
Jul 1, 2015	Twilio	$130.0M Series E	Fidelity Management & Research Company, T. Rowe Price Associates	Adeyemi Ajao, Bessemer Venture Partners, CapitalG, Chemistry VC, Drive Capital, Ensemble VC, Fifth Wall, FJ Labs, Founders Circle Capital, K2 Global, Kleiner Perkins, Roble Ventures, Sound Ventures, Trinity Ventures, TIM Ferriss, Altimeter Capital, Jeff B., John Somorjai
May 12, 2015	MarkLogic	$102.0M Other Equity	Wellington Management	Gary L. Bloom, Northgate Capital, Sequoia Capital, Tenaya Capital
Apr 1, 2012	Sapphire Energy	$140.0M Series C	—	ARCH Venture Partners, Monsanto

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jun 1, 2016	Mersana Therapeutics	$33.0M Series C	Wellington Management	Avoro Ventures, OrbiMed, Versant Ventures, Elliott Sigal, Cormorant Asset Management, NEW Enterprise Associates, Rock Springs Capital, Takeda
May 20, 2016	Convene	$35.0M Debt / Series B Extension	Brookfield Property Partners	Boathouse Capital, Conversion Capital, Sunrise Capital Partners
Aug 1, 2015	Syndax Pharmaceuticals	$80.0M Series C	Delos, Fidelity Management & Research Company	Amoon Fund, Domain Associates, InterWest, Osage University Partners, T1D Fund, Vivo Capital, Biomed Ventures, Cormorant Asset Management, EcoR1 Capital, Forward Ventures, Greenwood Capital, Jennison Associates, MPM Capital, OrbiMed, Rusnanomedinvest, Tavistock Group
Jul 1, 2015	Twilio	$130.0M Series E	Fidelity Management & Research Company, T. Rowe Price Associates	Adeyemi Ajao, Bessemer Venture Partners, CapitalG, Chemistry VC, Drive Capital, Ensemble VC, Fifth Wall, FJ Labs, Founders Circle Capital, K2 Global, Kleiner Perkins, Roble Ventures, Sound Ventures, Trinity Ventures, TIM Ferriss, Altimeter Capital, Jeff B., John Somorjai
May 12, 2015	MarkLogic	$102.0M Other Equity	Wellington Management	Gary L. Bloom, Northgate Capital, Sequoia Capital, Tenaya Capital
Apr 1, 2012	Sapphire Energy	$140.0M Series C	—	ARCH Venture Partners, Monsanto

Arrowpoint Partners

Subscribe, Save or Share

About

Investment Activity

Investments Made

Financial History

Deep Dive

Sources

Deep Dive

Sources

Investment Activity

Investments Made